Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 4 hrs 46 mins

S&P Futures
5,877.00
-19.25(-0.33%)
Dow Futures
43,054.00
-123.00(-0.28%)
Nasdaq Futures
20,441.25
-78.25(-0.38%)
Russell 2000 Futures
2,241.40
-14.10(-0.63%)
Crude Oil
70.20
-0.36(-0.51%)
Gold
2,750.00
+11.10(+0.41%)

Glenmark Pharmaceuticals Limited (GLENMARK.NS)

NSE - NSE Real Time Price. Currency in INR

Follow

1,702.40

-14.40

(-0.84%)

As of 02:14PM IST. Market open.

Previous Close	1,716.80
Open	1,717.45
Bid	1,701.65 x 0
Ask	1,702.00 x 0
Day's Range	1,690.00 - 1,741.75
52 Week Range	722.10 - 1,830.95
Volume	360,928
Avg. Volume	1,051,269

Market Cap	480.397B
Beta (5Y Monthly)	0.87
PE Ratio (TTM)	N/A
EPS (TTM)	-55.80
Earnings Date	Oct 24, 2024
Forward Dividend & Yield	2.50 (0.15%)
Ex-Dividend Date	Sep 13, 2024
1y Target Est	646.77

All

Pharmaceutical Technology
Glenmark to market BeiGene’s oncology medicines in India
Glenmark will manage the necessary development, registration and distribution processes of Tislelizumab and Zanubrutinib.
Pharmaceutical Technology
Cipla and Glenmark initiate recall of certain products in the US
Cipla USA is recalling 59,244 packs of Ipratropium Bromide and Albuterol Sulfate Inhalation Solution.